Literature DB >> 34815573

Cellular origins of dsRNA, their recognition and consequences.

Y Grace Chen1, Sun Hur2.   

Abstract

Double-stranded RNA (dsRNA) is associated with most viral infections - it either constitutes the viral genome (in the case of dsRNA viruses) or is generated in host cells during viral replication. Hence, nearly all organisms have the capability of recognizing dsRNA and mounting a response, the primary aim of which is to mitigate the potential infection. In vertebrates, a set of innate immune receptors for dsRNA induce a multitude of cell-intrinsic and cell-extrinsic immune responses upon dsRNA recognition. Notably, recent studies showed that vertebrate cells can accumulate self-derived dsRNAs or dsRNA-like species upon dysregulation of several cellular processes, activating the very same immune pathways as in infected cells. On the one hand, such aberrant immune activation in the absence of infection can lead to pathogenesis of immune disorders, such as Aicardi-Goutières syndrome. On the other hand, the same innate immune reaction can be induced in a controlled setting for a therapeutic benefit, as occurs in immunotherapies. In this Review, we describe mechanisms by which immunostimulatory dsRNAs are generated in mammalian cells, either by viruses or by the host cells, and how cells respond to them, with the focus on recent developments regarding the role of cellular dsRNAs in immune modulation.
© 2021. Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34815573      PMCID: PMC8969093          DOI: 10.1038/s41580-021-00430-1

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   113.915


  197 in total

1.  Cooperative assembly and dynamic disassembly of MDA5 filaments for viral dsRNA recognition.

Authors:  Alys Peisley; Cecilie Lin; Bin Wu; McGhee Orme-Johnson; Mengyuan Liu; Thomas Walz; Sun Hur
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

Review 2.  Double-Stranded RNA Sensors and Modulators in Innate Immunity.

Authors:  Sun Hur
Journal:  Annu Rev Immunol       Date:  2019-01-23       Impact factor: 28.527

3.  Structural analysis of RIG-I-like receptors reveals ancient rules of engagement between diverse RNA helicases and TRIM ubiquitin ligases.

Authors:  Kazuki Kato; Sadeem Ahmad; Zixiang Zhu; Janet M Young; Xin Mu; Sehoon Park; Harmit S Malik; Sun Hur
Journal:  Mol Cell       Date:  2020-12-28       Impact factor: 17.970

4.  Ubiquitin-induced oligomerization of the RNA sensors RIG-I and MDA5 activates antiviral innate immune response.

Authors:  Xiaomo Jiang; Lisa N Kinch; Chad A Brautigam; Xiang Chen; Fenghe Du; Nick V Grishin; Zhijian J Chen
Journal:  Immunity       Date:  2012-06-14       Impact factor: 31.745

5.  Ubiquitin-Dependent and -Independent Roles of E3 Ligase RIPLET in Innate Immunity.

Authors:  Cristhian Cadena; Sadeem Ahmad; Audrey Xavier; Joschka Willemsen; Sehoon Park; Ji Woo Park; Seong-Wook Oh; Takashi Fujita; Fajian Hou; Marco Binder; Sun Hur
Journal:  Cell       Date:  2019-04-18       Impact factor: 41.582

6.  Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses.

Authors:  Thiagarajan Venkataraman; Maikel Valdes; Rachel Elsby; Shigeru Kakuta; Gisela Caceres; Shinobu Saijo; Yoichiro Iwakura; Glen N Barber
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

7.  LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses.

Authors:  Takashi Satoh; Hiroki Kato; Yutaro Kumagai; Mitsutoshi Yoneyama; Shintaro Sato; Kazufumi Matsushita; Tohru Tsujimura; Takashi Fujita; Shizuo Akira; Osamu Takeuchi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-08       Impact factor: 11.205

8.  Structural basis for ubiquitin-mediated antiviral signal activation by RIG-I.

Authors:  Alys Peisley; Bin Wu; Hui Xu; Zhijian J Chen; Sun Hur
Journal:  Nature       Date:  2014-03-02       Impact factor: 49.962

Review 9.  Filament-like Assemblies of Intracellular Nucleic Acid Sensors: Commonalities and Differences.

Authors:  Cristhian Cadena; Sun Hur
Journal:  Mol Cell       Date:  2019-10-17       Impact factor: 17.970

10.  LGP2 plays a critical role in sensitizing mda-5 to activation by double-stranded RNA.

Authors:  Kay S Childs; Richard E Randall; Stephen Goodbourn
Journal:  PLoS One       Date:  2013-05-09       Impact factor: 3.240

View more
  7 in total

1.  Flipped over U: structural basis for dsRNA cleavage by the SARS-CoV-2 endoribonuclease.

Authors:  Meredith N Frazier; Isha M Wilson; Juno M Krahn; Kevin John Butay; Lucas B Dillard; Mario J Borgnia; Robin E Stanley
Journal:  Nucleic Acids Res       Date:  2022-08-12       Impact factor: 19.160

2.  FACT subunit SUPT16H associates with BRD4 and contributes to silencing of interferon signaling.

Authors:  Dawei Zhou; Zhenyu Wu; Jun-Gyu Park; Guillaume N Fiches; Tai-Wei Li; Qin Ma; Huachao Huang; Ayan Biswas; Luis Martinez-Sobrido; Netty G Santoso; Jian Zhu
Journal:  Nucleic Acids Res       Date:  2022-08-26       Impact factor: 19.160

Review 3.  A Dual Role of DDX3X in dsRNA-Derived Innate Immune Signaling.

Authors:  Juntae Kwon; Hyeongjwa Choi; Cecil Han
Journal:  Front Mol Biosci       Date:  2022-07-06

Review 4.  Bacterial origins of human cell-autonomous innate immune mechanisms.

Authors:  Tanita Wein; Rotem Sorek
Journal:  Nat Rev Immunol       Date:  2022-04-08       Impact factor: 108.555

5.  Flipped Over U: Structural Basis for dsRNA Cleavage by the SARS-CoV-2 Endoribonuclease.

Authors:  Meredith N Frazier; Isha M Wilson; Juno M Krahn; Kevin John Butay; Lucas B Dillard; Mario J Borgnia; Robin E Stanley
Journal:  bioRxiv       Date:  2022-03-02

Review 6.  Recent insights into the structure and function of coronavirus ribonucleases.

Authors:  Meredith N Frazier; Amanda A Riccio; Isha M Wilson; William C Copeland; Robin E Stanley
Journal:  FEBS Open Bio       Date:  2022-04-29       Impact factor: 2.792

Review 7.  The Pivotal Role of Chemical Modifications in mRNA Therapeutics.

Authors:  Albert Liu; Xiao Wang
Journal:  Front Cell Dev Biol       Date:  2022-07-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.